Načítá se...
Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment response
There has been little progress in the use of patient-derived xenografts (PDX) to guide individual therapeutic strategies. In part, this can be attributed to the operational challenges of effecting successful engraftment and testing multiple candidate drugs in a clinically workable timeframe. It also...
Uloženo v:
| Vydáno v: | NPJ Precis Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6041303/ https://ncbi.nlm.nih.gov/pubmed/30202792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-018-0060-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|